Registry to follow patients with a sirolimus stent
Part of Heart & circulation clinical trials.
This study is a follow-up registry that tracks how people do after doctors place a specific type of drug-eluting coronary stent. It may help doctors understand safety and outcomes of the Supraflex stent in real-world care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Sign consent allowing the study team to collect and use your medical information
- Your doctor has already planned and placed at least one Supraflex family sirolimus stent
- Be willing and able to return for follow-up visits and other study checks
- Not be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at patients who received a special type of heart stent (a small mesh tube that holds open a blocked artery) during a procedure called angioplasty at Geneva University Hospitals. The goal is to see how safe and effective this stent is in everyday practice.
This trial tests a new type of heart stent in people who also take daily blood thinners. The stent is very thin and releases medicine over time to help keep the artery open, and the coating eventually dissolves. It may be a safer option for people on blood thinners who need a stent.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
This registry enrolls adults who are about to get a heart stent and have significant blockage in their coronary arteries. It aims to collect real-world information about stenting for different types of heart conditions, which may help improve future care.
This study follows adults with blocked heart arteries who are treated using a special type of balloon (drug-coated balloon) during a procedure. It aims to track real-world outcomes to better understand how well this treatment works for people with new blockages or previously treated vessel narrowing.
This trial tests a new stent (a small mesh tube) to open narrowed heart arteries and improve blood flow. It may help people with multiple blocked arteries who are having a procedure to widen them.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.